Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Adelaide, adult, algae, allowfor, andAvigen, anddevelopment, Appendix, ascending, associatedwith, attenuation, behavior, blind, botanical, byapproximately, cannabinoid, carbohydrate, CFO, clinicaldevelopment, comparedto, completionof, curtain, datedNovember, description, Dilly, discretion, discrimination, double, estimateof, experiencein, figure, footage, forany, forfeiture, forty, fourth, GAAP, Global, grantbased, graph, higheraverage, ibudilast, IIa, incompliance, indefinitely, index, inJanuary, involuntary, iron, issueable, Jan, jointly, landlord, lifetime, likelihood, memory, MicroCap, mitigate, muranishi, nausea, neededto, neutralize, nonemployee, nonrefundable, odenberg, Ohrstrom, OptionPlan, organizational, ourassignment, Overview, partiallyoffset, partly, payoff, perpetual, placebo, qualitative, quantify, quantifying, RDG, receiveregulatory, reconfigure, reinvestment, remeasured, Richard, rollover, Royal, SAB, sea, slight, spacticity, Stephen, street, theamount, track, ullakko, uncorrected, unlimited, unrecognized, visual, vomiting, windfall, withdrawl, withour
Removed:
absence, actively, Addiction, Alzheimer, amputation, automatic, billion, biotechnical, body, book, called, cancer, central, Chairman, circulating, classify, Collagen, Columbia, commenced, constipation, consumption, daily, damage, Dawn, death, deferring, dementia, device, dilution, edema, endure, epilepsy, Eunoe, experimental, fellowship, fewer, foundation, Gehrig, healthcare, HIV, hope, increasing, ineffective, injected, Institute, interact, intrathecal, invited, issuing, itching, IX, leadership, lidocaine, Lou, McGuire, medication, mild, moderate, movement, neural, neurologist, neurology, newly, nonqualified, notice, pathophysiology, Pennsylvania, prevalence, Princeton, put, reducing, remained, repay, requiring, Reviewer, revision, rodent, scheduling, School, sensation, short, side, size, Society, spent, stigma, stroke, timetable, traditionally, trained, tramadol, transferring, tricyclic, variable, worldwide, ziconotide, zoster
Filing tables
Filing exhibits
- 10-K Annual report
- 10.63 Offer Letter with DR. Stephen Dilly
- 10.64 Offer Letter with DR. Jan Ohrstrom
- 23.1 Consent of Odenberg, Ullakko, Muranishi & Co. LLP
- 23.2 Consent of Ernst & Young LLP
- 31.1 CEO Certification Required by Rule 13A-14(A)
- 31.2 CFO Certification Required by Rule 13A-14(A)
- 32.1 Certification Required by Rule 13A-14(B)
Related press release
AVGN similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Kenneth Chahine, Chief Executive Officer of Avigen, Inc. (the “Company”), and Andrew A. Sauter, Vice President, Finance of the Company, each hereby certify that, to the best of his knowledge:
1. | The Company’s Annual Report on Form 10-K for the period ended December 31, 2006, and to which this Certification is attached as Exhibit 32.1, (the “Periodic Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and | ||
2. | The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
In Witness Whereof, the undersigned have set their hands hereto as of the 14th day of March, 2007.
/s/ KENNETH G. CHAHINE | |
Kenneth G. Chahine | |
Chief Executive Officer | |
/s/ ANDREW A. SAUTER | |
Andrew A. Sauter | |
Vice President, Finance |